kynurenic acid

Small moleculeexperimental

Kynurenic acid is a product of the normal metabolism of amino acid L-tryptophan. It has been shown that kynurenic acid possesses neuroactive activity. It acts as an antiexcitotoxic and anticonvulsant, most likely through acting as an antagonist at excitatory amino acid receptors. Because of this activity, it may influence important neurophysiological and neuropathological processes. As a result, kynurenic acid has been considered for use in therapy in certain neurobiological disorders. Conversely, increased levels of kynurenic acid have also been linked to certain pathological conditions. — Wikipedia

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • kynurenic acid
  • kynurenic acid
  • kynurenic acid

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06807021Phase 2/Phase 3 (Phase 3)Dec 1, 2025Birch BioMed Inc, Nutrasource Diagnostics
NCT04186273Phase 2Nov 25, 2019University of British Columbia
NCT02340325Phase 1May 1, 2015BC Professional Fire Fighters' Burn and Wound Healing Laboratory, British Columbia Professional Firefighters' Burn and Wound Healing Laboratory
Showing 3 of 3 trials
Page 1 / 1

Organizations

Research & Development (5)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
BC Professional Fire Fighters' Burn and Wound Healing LaboratoryAcademic/Hospital1012015
Birch BioMed IncFor profit1112025
British Columbia Professional Firefighters' Burn and Wound Healing LaboratoryAcademic/Hospital1112015
Nutrasource DiagnosticsFor profit1012025
University of British ColumbiaAcademic/Hospital1112019
5 organizations
Page 1 / 1